Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open-label, paired-comparison, clinical trial
Authors:
F. Dall'Oglio a;
M. R. Nasca a;
M. L. Musumeci a;
G. La Torre b;
G. Ricciardi b;
C. Potenza c;
G. Micali a
| Affiliations: | a Dermatology Clinic, University of Catania, Catania, Italy |
| b Institute of Hygiene, Catholic University, Rome, Italy | |
| c Dermatology Clinic, University La Sapienza, Rome, Italy |
DOI:
10.1080/09546630410023601
Publication Frequency:
6 issues per year
Subject:
Dermatology;
Number of References: 21
Formats available:
HTML
(English)
:
PDF
(English)
Cited By
This article is cited by 1 other article. You must have access to this article in order to view its citations.


Download Citation


